Related Experiment Video

Updated: Aug 4, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

1.9K

Heart failure with reduced ejection fraction: What's new in the 2022 guideline?

Michelle M Kittleson1

  • 1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Writing Committee Member, 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure Michelle.kittleson@cshs.org.

Cleveland Clinic Journal of Medicine
|April 3, 2023
PubMed

Insights

The 2022 heart failure guideline offers practical advice for patient care. It focuses on key updates for managing heart failure with reduced ejection fraction (HFrEF) to improve daily practice.

Area of Science:

  • Cardiology
  • Heart Failure Management
  • Clinical Practice Guidelines

Background:

  • The 2022 American College of Cardiology, American Heart Association, and Heart Failure Society of America guideline offers comprehensive recommendations for heart failure.
  • Effective management of heart failure with reduced ejection fraction (HFrEF) is crucial for patient outcomes.

Purpose of the Study:

  • To summarize the most critical recommendations from the 2022 guideline.
  • To provide practical insights into implementing these recommendations for HFrEF patient management.
  • To guide clinicians in adapting their daily practice based on the latest evidence.

Main Methods:

  • Review and synthesis of the 2022 American College of Cardiology, American Heart Association, and Heart Failure Society of America guideline.
  • Focus on recommendations specifically pertaining to the management of heart failure with reduced ejection fraction (HFrEF).
  • Analysis of how these recommendations translate into actionable clinical practice changes.

Main Results:

  • Key updates in pharmacotherapy for HFrEF.
  • Guidance on device therapy and management of comorbidities in HFrEF.
  • Emphasis on patient-centered care and shared decision-making.

Conclusions:

  • The 2022 guideline provides essential updates for managing patients with HFrEF.
  • Implementation of these recommendations can optimize patient care and outcomes.
  • Clinicians should integrate these findings into their daily practice for improved heart failure management.

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.9K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
20
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
19
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
475
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K